CCO Treatment Updates
Current Treatment Options in Acute Lymphoblastic Leukemia
Module
Current Treatment Options in Acute Lymphoblastic Leukemia
|
Program Director: Martin S. Tallman, MD
|
|
Dan Douer, MD, reviews current standards of care for adults and children with ALL and explores changes in the treatment landscape with the potential to improve outcomes.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the roles of both autologous and allogeneic hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia
- Compare treatment strategies for adults and children with acute lymphoblastic leukemia
- Consider appropriate pediatric protocols to treat adolescent and adult patients with acute lymphoblastic leukemia
- Summarize the use of central nervous system prophylaxis in the treatment of patients with acute lymphoblastic leukemia
- Contrast treatment of Philadelphia chromosome–positive and –negative acute lymphoblastic leukemia
Abstract
|
Interactive Virtual Presentations
Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia
|
Program Director: Martin S. Tallman, MD
|
|
Jacob M. Rowe, MD, FACP, explores current thinking regarding treatment strategies for adults with acute lymphoblastic leukemia.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe current treatment approaches in Philadelphia chromosome–positive acute lymphoblastic leukemia
- Compare results of recent clinical studies evaluating the role of allogeneic transplantation in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
- Contrast reduced-intensity conditioning regimens used before allogeneic transplantation in patients with acute lymphoblastic leukemia
- Identify treatment options for acute lymphoblastic leukemia that is resistant to or refractory to imatinib
|
Slideset: Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia
 |
|
Download a slide presentation by Jacob M. Rowe, MD, FACP, focusing on allogeneic transplantation in patients with Philadelphia chromosome–positive ALL.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.95 MB
| Date posted: 4/30/2009
|
ALL in Special Populations: Adolescents/Young Adults and Older Adults
|
Program Director: Martin S. Tallman, MD
- Adele K. Fielding, MB BS, PhD, FRCP, FRCPath
|
|
|
Adele K. Fielding, MB BS, PhD, FRCP, FRCPath, reviews strategies to improve treatment outcomes in 2 special patient populations affected by ALL: young adults and the elderly.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify factors that contribute to age-related differences in outcomes in adult patients with acute lymphoblastic leukemia (ALL)
- Describe the differences between adult and pediatric ALL treatment protocols
- Discuss strategies to optimize outcomes in adolescent/young adult patients with ALL
- Examine treatment considerations for older adults with ALL
|
Slideset: ALL in Special Populations: Adolescents/Young Adults and Older Adults
 |
|
Download a presentation by Adele K. Fielding, MB BS, PhD, FRCP, FRCPath, in which she reviews treatment strategies in 2 special patient populations affected by ALL: young adults and the elderly.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.75 MB
| Date posted: 4/23/2009
|
Disclaimer:
The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|